Wellgistics Health CEO Tim Canning to Exit, Brian Norton Named Successor

Dow Jones
03-05
 

By Sabela Ojea

 

Wellgistics Health said Chief Executive Tim Canning is leaving after about a year in the role and will be succeeded by Brian Norton.

The holding company centered around pharmaceuticals and healthcare services on Tuesday said that the appointment of Norton comes at a pivotal time for the company as it continues to streamline operations and expand market reach.

Under his leadership, the company will focus on enhancing operational efficiencies, optimizing sales and marketing strategies, advancing its technology roadmap, and remaining disciplined in executing on acquisition opportunities.

Norton has a proven track record of success and expertise in healthcare, technology, and pharmaceutical supply chain innovation and has led high-performing teams to accelerate market growth and revenue recognition, the company said.

 

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

 

(END) Dow Jones Newswires

March 04, 2025 17:35 ET (22:35 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10